-- Announcement on Adding Extraordinary Proposal and Postponement of the 1st Extraordinary General Meeting in 2025
Securities code: 688180 Securities abbreviation: Junshi Biotechnology Announcement number: Lin 2025-052
Shanghai Junshi Biomedical Technology Co., Ltd.
Announcement on the addition of temporary proposals and postponement of the first extraordinary general meeting of shareholders in 2025
The company's board of directors and all directors guarantee that the announcement does not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents in accordance with the law.
1. Relevant situation of shareholders’ meeting
- Type and session of the original shareholders’ meeting:
The first extraordinary general meeting of shareholders in 2025
Original shareholders’ meeting date: September 26, 2025
Equity registration date of the original shareholders’ meeting:
Share class Stock code Stock abbreviation Equity registration date
A shares 688180 Junshi Biotechnology 2025/9/19
For information on registration and participation of H-share shareholders, please refer to the company’s notices and circulars of the above-mentioned general meeting of shareholders published on the website of the Hong Kong Stock Exchange (www.hkexnews.hk) and the company’s website (www.junshipharma.com).
2. Add the specific content and reasons involved in the temporary proposal and postponement of the meeting
(1) Specific circumstances and reasons for adding temporary proposals
Proposer: Xiong Jun
Description of proposal procedure
The company has announced the convening notice of the shareholders' meeting on September 6, 2025. Mr. Xiong Jun, a shareholder and chairman who individually holds more than 1% of the company's shares, proposed a temporary proposal on September 15, 2025 and submitted it in writing to the convener of the shareholders' meeting. The convener of the general meeting of shareholders is hereby making an announcement in accordance with the relevant provisions of the "Self-Regulatory Guidelines for Companies Listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange No. 1 - Standardized Operations".
- Specific contents of the provisional proposal
On September 15, 2025, the company's board of directors received the "Letter of Proposal for Adding Temporary Proposals to the First Extraordinary General Meeting of Shareholders of Shanghai Junshi Biomedical Technology Co., Ltd. in 2025" submitted by Mr. Xiong Jun, a shareholder and chairman who alone holds more than 1% of the company's shares, and requested the company's board of directors to add to the agenda of the first extraordinary general meeting of shareholders in 2025 "About the proposal to award Mr. Zhang Zhuobing H after the adoption of the company's 2025 H-share stock option incentive plan." "Proposal on Proposing to Grant H-Share Stock Options to Mr. SHENGYAO (Yao Sheng) after the Company's 2025 H-Share Stock Option Incentive Plan is Adopted".
(2) Reasons for postponing the general meeting of shareholders
The company was originally scheduled to hold the first extraordinary general meeting of shareholders in 2025 on September 26, 2025. Due to the company's overall work arrangement needs, based on the company's actual situation, and based on careful consideration and to ensure the smooth convening of the general meeting of shareholders, the company decided to postpone the first extraordinary general meeting of shareholders in 2025 to September 29, 2025. The original equity registration date remains unchanged.
- In addition to the above-mentioned additional temporary proposals and postponement of the meeting, the original meeting announced on September 6, 2025
Other matters in the notice of general meeting of shareholders remain unchanged.
4. Add temporary proposals and relevant information on the postponed shareholders’ meeting.
- Date, time and place of on-site meeting
Convening date and time: 14:40 on September 29, 2025
Venue: Floor 15, Building 7, No. 6, Lane 100, Pingjiaqiao Road, Pudong New District, Shanghai
- Online voting system, start and end dates and voting time.
Online Voting System: Shanghai Stock Exchange Shareholders Meeting Online Voting System
Online voting starts and ends on September 29, 2025
Until September 29, 2025
Using the Shanghai Stock Exchange's online voting system, the voting time through the trading system voting platform is the trading time period on the day the shareholders' meeting is held, that is, 9:15-9:25, 9:30-11:30, 13:00-15:00; the voting time through the Internet voting platform is 9:15-15:00 on the day the shareholders' meeting is held.
- Equity registration date
The equity registration date of the original notice of the general meeting of shareholders remains unchanged. For other relevant matters, please refer to the "Notice of Shanghai Junshi Biomedical Technology Co., Ltd. on convening the first extraordinary general meeting of shareholders in 2025" disclosed by the company on the website of the Shanghai Stock Exchange (www.sse.com.cn) on September 6, 2025 (announcement number: Lin 2025-049).
- Shareholders’ Meeting Proposals and Voting Shareholder Types
Voting shareholder type serial number Proposal name
Non-cumulative voting resolutions for A-share shareholders and H-share shareholders
1 Proposal on the election of independent non-executive directors √ 2 Proposal on the revision of some internal management systems √ 3 Proposal on changes in registered capital, cancellation of the Board of Supervisors, amendments to the Company √
Proposals on the Articles of Association and its Annexes
4 Regarding the "Company's 2025 A-Share Stock Option Incentive Plan (Draft)" and its summary and suggestions, a director and major shareholder
Proposal for granting A-share stock options
5 Regarding the Implementation of the Company’s 2025 A-Share Stock Option Incentive Plan √
Proposal on Implementing Assessment Management Measures
6 Regarding the proposal to the shareholders’ meeting to authorize the board of directors to handle the company 2025 √
Proposal on matters related to the A-share stock option incentive plan in 2017
7 About the "Company's 2025 H-Share Stock Option Incentive Plan" √
motion
8 Regarding the proposal to the general meeting of shareholders to authorize the board of directors and/or plan management personnel to handle the company’s 2025 H-share stock option incentive plan
motions on matters
9 Discussion on the proposal to grant H-share stock options to Mr. Zhang Zhuobing after the adoption of the company’s 2025 H-share stock option incentive plan
case
10 Regarding the adoption of the company’s 2025 H-share stock option incentive plan √
After receiving the proposal, it is recommended to grant H shares to Mr. SHENGYAO (Yao Sheng)
stock option motion
(1) Special resolutions: Proposals 3, 4, 5, 6, 7, 8, 9 and 10 of the first extraordinary general meeting of shareholders in 2025
(2) Proposal to count votes separately for small and medium-sized investors: No. 1, 4, 5, 6, 2025 First Extraordinary General Meeting of Shareholders
7, 8, 9 and 10 proposals
(3) Proposals involving related shareholders’ avoidance of voting: No. 4, 5, 6, 7, 2025 First Extraordinary General Meeting of Shareholders
8, 9, 10 motions
Name of related shareholders who should avoid voting: Shareholders who are intended to be incentive targets or shareholders who are related to incentive targets should avoid voting.
(4) Proposals involving preference shareholders’ participation in voting: Not involved
Announcement is hereby made.
Board of Directors of Shanghai Junshi Biomedical Technology Co., Ltd.
September 16, 2025 Attachment 1: Power of Attorney
Power of attorney
Shanghai Junshi Biomedical Technology Co., Ltd.:
I hereby authorize Mr. (Ms.) to represent the company (or myself) to attend the 2025 first extraordinary general meeting of shareholders of your company to be held on September 29, 2025, and to exercise voting rights on my behalf.
Number of common shares held by the client:
Client shareholder account number:
Serial number Name of non-cumulative voting motion Agree Oppose Abstain 1 Proposal on the election of independent non-executive directors 2 Proposal on the revision of some internal management systems
case
3 Regarding changes in registered capital, cancellation of the board of supervisors,
Proposal 4 to amend the "Articles of Association" and its attachments regarding the "Company's 2025 A-Share Stock Option Incentive Plan (Draft)" and its summary and recommendations to grant A to a director and major shareholder
stock option motion
5 Discussion on the "Measures for the Implementation Assessment and Management of the Company's 2025 A-Share Stock Option Incentive Plan"
case
6 Regarding the proposal to the shareholders’ meeting to authorize the board of directors to handle the company’s 2025 A-share stock option incentives
Proposals on matters related to the plan
7 About "The Company's 2025 H-Share Stock Options"
Proposal on Incentive Plan
8 Regarding the proposal to the shareholders’ meeting to authorize the board of directors and/or
or the plan administrator’s proposal to handle matters related to the company’s 2025 H-share stock option incentive plan
9 Proposal on the proposal to grant H-share options to Mr. Zhang Zhuobing after the company’s 2025 H-share stock option incentive plan is adopted
10 Proposal on the proposal to grant H-share options to Mr. SHENG YAO (Yao Sheng) after the company’s 2025 H-share stock option incentive plan is adopted
Signature (seal) of the principal:
Trustee’s signature:
Client’s ID number:
Trustee ID number:
Commission date: year month day
Remarks:
The client should choose one of the "agree", "objection" or "abstain" intentions in the power of attorney and tick "√". If the client does not give specific instructions in this power of attorney, the trustee has the right to vote according to his own wishes.